A Novel Valsalva Assist Device for Terminating Supraventricular Tachycardia

NACompletedINTERVENTIONAL
Enrollment

212

Participants

Timeline

Start Date

March 1, 2022

Primary Completion Date

April 30, 2023

Study Completion Date

May 30, 2024

Conditions
Supraventricular Tachycardia (SVT)
Interventions
DEVICE

Valsalva assist device

A valsalva assist device designed to provide the recommended resistance to exhalation at a pressure of 40 mmHg.

OTHER

standard Valsalva manoeuvre

The Valsalva manoeuvre is carried out without any device.

Trial Locations (1)

100010

Capital Medical University affiliated Beijing Anzhen Hospital, Beijing

All Listed Sponsors
lead

Beijing Anzhen Hospital

OTHER